Comparison of the effects of pilocarpine and cevimeline on salivary flow.

OBJECTIVE The aim of the present study was to compare the effect of low-dose pilocarpine and cevimeline as stimulants for salivary flow in healthy subjects. METHODS In this cross-over clinical trial with a 1-week washout period, 40 male volunteers were submitted to an oral dose of pilocarpine 1% (Salagen) -60 microg kg(-1) body-weight (Group 1) or Cevimeline (Evoxac) -30 mg (Group 2). Saliva samples were collected and the salivary flow rate was measured (ml min(-1)) at baseline and 20, 40, 60, 80, 140 and 200 min after administration of drugs. In addition, salivary secretion was also measured under mechanical stimulation to observe salivary gland function. RESULTS The data were analyzed by Friedman and Wilcoxon signed-rank tests (significance level = 5%). Pilocarpine and cevimeline significantly increased salivary flow 140 min after intake. There was a significant higher secretion with cevimeline 140 and 200 min after administration. There were no differences seen among subjects in the salivary glands function by mechanical stimulation. CONCLUSION Both drugs showed efficacy in increasing the salivary flow in healthy volunteers, but cevimeline was more effective than pilocarpine.

[1]  Christopher U. Jones,et al.  Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[2]  K. Ono,et al.  Relationship of chewing-stimulated whole saliva flow rate and salivary gland size. , 2007, Archives of oral biology.

[3]  M. P. Goldie.  Xerostomia and quality of life , 2007 .

[4]  J. Atkinson,et al.  Salivary hypofunction and xerostomia: diagnosis and treatment. , 2005, Dental clinics of North America.

[5]  Charles G. Martin,et al.  Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[6]  M. Mínguez,et al.  Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. , 2004, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[7]  K. Tsubota,et al.  Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study. , 2004, American journal of ophthalmology.

[8]  Philip C. Fox,et al.  Salivary Enhancement Therapies , 2004, Caries Research.

[9]  M. Greenberg,et al.  Pilocarpine toxicity and the treatment of xerostomia. , 2004, The Journal of emergency medicine.

[10]  E. Veerman,et al.  Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies , 2003, Supportive Care in Cancer.

[11]  E. Tindall,et al.  Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. , 2002, Archives of internal medicine.

[12]  Stanley B. Cohen,et al.  A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. , 2002, Arthritis and rheumatism.

[13]  Y. Konttinen,et al.  Use of muscarinic agonists in the treatment of Sjögren's syndrome. , 2001, Clinical immunology.

[14]  F. Vivino.  The treatment of Sjögren's syndrome patients with Pilocarpine-tablets , 2001, Scandinavian journal of rheumatology. Supplement.

[15]  R. Fox,et al.  Approaches to the treatment of Sjögren's syndrome. , 2000, The Journal of rheumatology. Supplement.

[16]  Daniels Te.  Evaluation, differential diagnosis, and treatment of xerostomia. , 2000, The Journal of rheumatology. Supplement.

[17]  R. Wynn,et al.  Artificial saliva products and drugs to treat xerostomia. , 2000, General dentistry.

[18]  R. López,et al.  [Kinetic assessment of salivary secretory response to citric acid. Differences with pilocarpine]. , 1998, Revista medica de Chile.

[19]  R. Nagler,et al.  Relationships between age, drugs, oral sensorial complaints and salivary profile. , 2005, Archives of oral biology.

[20]  C Scully,et al.  An update of the etiology and management of xerostomia. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[21]  H. M. Barros,et al.  Effect of pilocarpine mouthwash on salivary flow. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  L. Escalona,et al.  Manejo Terapeútico del paciente con Xerostomía , 2001 .

[23]  H. Joensuu,et al.  Pilocarpine and carbacholine in treatment of radiation-induced xerostomia. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.